Stay updated on Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with a generic error page; this change blocks access to the study's details and related sections.
    Difference
    16%
    Check dated 2026-09-19T20:11:21.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing v3.6.5, indicating a small maintenance update with no changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-29T20:10:19.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a new revision label, Revision: v3.6.5, replacing the previous Revision: v3.6.4, signaling a small update to the page's versioning. This change is a metadata update and does not affect the study content or eligibility details.
    Difference
    0.1%
    Check dated 2026-08-08T18:21:36.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a new build of the page.
    Difference
    0.1%
    Check dated 2026-07-25T10:20:55.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.2 to v3.6.3, indicating a small site update with no visible changes to the study details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-03T22:36:12.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.0 to v3.6.2, signaling an internal update to the site's backend or documentation rather than any change to the clinical trial details presented.
    Difference
    0.1%
    Check dated 2026-06-26T19:38:05.000Z thumbnail image

Stay in the know with updates to Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.